Johnson & Johnson Will Pay $2.2 Billion

Johnson & Johnson Will Pay $2.2 Billion to Settle Charges of Illegally Promoting Antipsychotic Drug This past month Johnson & Johnson agreed to pay more than $2.2 billion in fines to settle accusations that it improperly promoted the antipsychotic drug Risperdal to older adults and children. It is the third-largest pharmaceutical settlement ever in the […]

Obesity and Psychiatry

Obesity and Psychiatry On June 18, 2013 the American Medical Association voted to declare obesity a disease. Obesity and various eating disorders have been a topic of discussion at the American Psychiatric Association for some time. The debate continues, whether to declare obesity a psychiatric disorder or not. Obese: (medical definition) An abnormal accumulation of […]

Fake Article in Psych Research Journal

Fake Article in Psych Research Journal A Norwegian study that claims to have observed significant brain changes in mental patients who switched from so-called “first generation” antipsychotic drugs to second generation varieties has been retracted from the peer-reviewed journal BMC Research Notes. As announced by Retraction Watch, the foiled paper was pulled after it was […]